The experimental coronavirus treatment leronlimab has shown a “very promising” response in COVID-19 patients with mild-to-moderate symptoms, according to developer CytoDyn. Leronlimab is a viral-entry inhibitor that targets HIV and breast cancer. The drug has also been attracting attention as a potential coronavirus treatment. FoxNews
Monday, April 13, 2020
Experimental coronavirus treatment leronlimab shows 'very promising' response in some COVID-19 patients
The experimental coronavirus treatment leronlimab has shown a “very promising” response in COVID-19 patients with mild-to-moderate symptoms, according to developer CytoDyn. Leronlimab is a viral-entry inhibitor that targets HIV and breast cancer. The drug has also been attracting attention as a potential coronavirus treatment. FoxNews
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment